地域連携感染制御学講座
緑膿菌感染症研究会
第50回緑膿菌感染症研究会
第7回私立医科大学病院感染対策協議会
第22回マクロライド新作用研究会
研究室メンバー専用

お問い合わせ・連絡先

東邦大学 医学部
微生物・感染症学講座
（医学部 １号館 ９階）

〒143-8540
東京都大田区大森西5-21-16
TEL 03-3762-4151

2021年

【英文誌 (順不同)】

 

  1. Takahashi S, Yasuda M, Wada K, Matsumoto M, Hayami H, Kobayashi K, Miyazaki J, Kiyota H, Matsumoto T, Yotsuyanagi H, Tateda K, Sato J, Hanaki H, Masumori N, Hiyama Y, Egawa S, Yamada H, Matsumoto K, Ishikawa K, Yamamoto S, Togo Y, Tanaka K, Shigemura K, Uehara S, Kitano H, Kiyoshima K, Hamasuna R, Ito K, Hirayama H, Kawai S, Shiono Y, Maruyama T, Ito S, Yoh M, Ito M, Hatano K, Ihara H, Uno S, Monden K, Yokoyama T, Takayama K, Sumii T, Kadena H, Kawahara M, Hosobe T, Izumitani M, Kano M, Nishimura H, Fujita R, Kaji S, Hayashi K, Tojo T, Matumura M. 2022. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan: Comparison with the first surveillance report. J Infect Chemother 28:1–5.
  2. Harada S, Aoki K, Ohkushi D, Okamoto K, Takehana K, Akatsuchi T, Ida K, Shoji D, Ishii Y, Doi Y, Moriya K, Hayama B. 2021. Institutional outbreak involving multiple clades of IMP-producing Enterobacter cloacae complex sequence type 78 at a cancer center in Tokyo, Japan. BMC Infect Dis 21.Ishii Y, Aoki K, Oda M, Ichikawa M, Moriuchi R, Konishi H, Nagashima M, Sadamasu K, Sugishita Y. 2021. A study of quality assessment in SARS-CoV-2 pathogen nucleic acid amplification tests performance; from the results of external quality assessment survey of clinical laboratories in the Tokyo Metropolitan Government external quality assessment program in 2020. J Infect Chemother https://doi.org/10.1016/j.jiac.2021.10.027.
  3. Sugita Kayoko, Aoki Kotaro, Komori Kohji, Nagasawa Tatsuya, Ishii Yoshikazu, Iwata Satoshi, Tateda Kazuhiro, Castanheira Mariana. 2021. Molecular Analysis of blaKPC-2-Harboring Plasmids: Tn4401a Interplasmid Transposition and Tn4401a-Carrying ColRNAI Plasmid Mobilization from Klebsiella pneumoniae to Citrobacter europaeus and Morganella morganii in a Single Patient. mSphere 0:e00850–21.
  4. Aoki K, Takai K, Nagasawa T, Kashiwagi K, Mori N, Matsubayashi K, Satake M, Tanaka I, Kodama N, Shimodaira T, Ishii Y, Miyazaki T, Ishii T, Morita T, Yoshimura T, Tateda K. 2021. Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis. Ann Lab Med 41:568–576.
  5. Yamada K, Sasaki M, Aoki K, Nagasawa T, Murakami H, Ishii M, Shibuya K, Morita T, Ishii Y, Tateda K. 2021. Pseudomonas tohonis sp. nov., isolated from the skin of a patient with burn wounds in Japan. Int J Syst Evol Microbiol 71.
  6. Ohama Y, Aoki K, Harada S, Nagasawa T, Sawabe T, Nonaka L, Moriya K, Ishii Y, Tateda K. 2021. Genetic Environment Surrounding blaOXA-55-like in Clinical Isolates of Shewanella algae Clade and Enhanced Expression of bla OXA-55-like in a Carbapenem-Resistant Isolate. mSphere https://doi.org/10.1128/msphere.00593-21.
  7. Nishio J, Negishi H, Yasui-Kato M, Miki S, Miyanaga K, Aoki K, Mizusawa T, Ueno M, Ainai A, Muratani M, Hangai S, Yanai H, Hasegawa H, Ishii Y, Tanji Y, Taniguchi T. 2021. Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis. Sci Rep 11:20231.
  8. Saito T, Muto K, Tanaka M, Okabe N, Oshitani H, Kamayachi S, Kawaoka Y, Kawana A, Suzuki M, Tateda K, Nakayama H, Yoshida M, Imamura A, Ohtake F, Ohmagari N, Osaka K, Kaku M, Sunagawa T, Nakashima K, Nishiura H, Wada K, Omi S, Wakita T. 2021. Proactive Engagement of the Expert Meeting in Managing the Early Phase of the COVID-19 Epidemic, Japan, February-June 2020. Emerg Infect Dis 27:1–9.
  9. Kashiwagi K, Maeda T, Yoshizawa S, Sato T, Aoki K, Ishii Y, Tateda K. 2021. IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan. J Nippon Med Sch 88:380–383.
  10. Okajima Y, Suzuki T, Miyazaki C, Goto S, Ishikawa S, Suzuki Y, Aoki K, Ishii Y, Tateda K, Hori Y. 2021. Metagenomic Shotgun Sequencing Analysis of Canalicular Concretions in Lacrimal Canaliculitis Cases. Curr Issues Mol Biol 43:676–686.
  11. Ueda T, Takesue Y, Matsumoto T, Tateda K, Kusachi S, Mikamo H, Sato J, Hanaki H, Mizuguchi T, Morikane K, Kobayashi M, Harihara Y, Seki S, Ishida Y, Fukushima R, Hada M, Matsuo Y, Kubo S, Kimura Y, Hata H, Nakajima K, Ohge H, Akagi S, Takeda S, Fukui Y, Suzuki K, Okamoto K, Yanagihara K, Kawamura H. 2021. Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nation-wide surveillance study. J Infect Chemother 27:931–939.
  12. Yamada K, Sasaki M, Murakami H, Aoki K, Morita T, Ishii Y, Tateda K. 2021. Evaluation of the simplified carbapenem inactivation method as a phenotypic detection method for carbapenemase-producing Enterobacterales. J Microbiol Methods 106273.
  13. Hanao M, Aoki K, Ishii Y, Shimuta K, Ohnishi M, Tateda K. 2021. Molecular characterization of Neisseria gonorrhoeae isolates collected through a national surveillance programme in Japan, 2013: evidence of the emergence of a ceftriaxone-resistant strain from a ceftriaxone-susceptible lineage. J Antimicrob Chemother https://doi.org/10.1093/jac/dkab104.
  14. Sakai T, Azuma Y, Aoki K, Wakayama M, Miyoshi S, Kishi K, Tateda K, Homma S, Iyoda A. 2021. Elective lung resection after treatment for COVID-19 pneumonia. Gen Thorac Cardiovasc Surg https://doi.org/10.1007/s11748-021-01630-4.
  15. McKee HK, Kajiwara C, Yamaguchi T, Ishii Y, Shimizu N, Ohara A, Tateda K. 2021. Clostridioides difficile toxins enhanced the in vitro production of CXC chemokine ligand 2 and tumor necrosis factor-α via Toll-like receptors in macrophages. J Med Microbiol 70.
  16. Hamada M, Yamaguchi T, Sato A, Ono D, Aoki K, Kajiwara C, Kimura S, Maeda T, Sasaki M, Murakami H, Ishii Y, Tateda K. 2021. Increased Incidence and Plasma-Biofilm Formation Ability of SCCmec Type IV Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Patients With Bacteremia. Front Cell Infect Microbiol 11:602833.
  17. Collins DA, Wu Y, Tateda K, Kim H-J, Vickers RJ, Riley TV. 2021. Evaluation of the antimicrobial activity of ridinilazole and six comparators against Chinese, Japanese and South Korean strains of Clostridioides difficile. J Antimicrob Chemother 76:967–972.
  18. Yamada K, Aoki K, Nagasawa T, Sasaki M, Murakami H, Ishii T, Ujiie S, Morita T, Ishii Y, Tateda K. 2021. Complete whole-genome sequence of the novel Pseudomonas species strain TUM18999, isolated from a patient with a burn wound in Japan. J Glob Antimicrob Resist 24:395–397.
  19. Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota J-I, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A. 2021. Clinical manifestations of adult patients requiring influenza-associated hospitalization: A prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother 27:480–485.
  20. Maeda T, Kashiwagi K, Yoshizawa S, Sato T, Aoki K, Ishii Y, Tateda K. 2021. Early anti-SARS-CoV-2 immunoglobulin G response may be associated with disease severity in patients with COVID-19. Jpn J Infect Dis https://doi.org/10.7883/yoken.JJID.2020.799.
  21. Ishii T, Sasaki M, Yamada K, Kato D, Osuka H, Aoki K, Morita T, Ishii Y, Tateda K. 2021. Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis. J Infect Chemother https://doi.org/10.1016/j.jiac.2021.02.025.
  22. Aoki K, Ishii Y, Tateda K. 2021. Detection of associated bacteria in aspiration pneumonia and lung abscesses using partial 16S rRNA gene amplicon sequencing. Anaerobe 69:102325.
  23. Aoki K, Nagasawa T, Ishii Y, Yagi S, Kashiwagi K, Miyazaki T, Tateda K. 2021. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2. J Infect Chemother 27:319–322.
  24. Kashiwagi K, Ishii Y, Aoki K, Yagi S, Maeda T, Miyazaki T, Yoshizawa S, Aoyagi K, Tateda K. 2021. Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother 27:384–386.
  25. Ishiwada N, Fujimaki K, Matsumoto T, Kiyota H, Tateda K, Sato J, Hanaki H, Takayanagi R, Yamaguchi Y, Hoshino T, Kuroki H, Iwata S, Tajima T, Horikoshi Y, Shiro H, Bamba M, Kawamura N, Ouchi K, Matsubara K, Okada T, Furuno K, Tsumura N. 2021. Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: General overview of pathogenic antimicrobial susceptibility. J Infect Chemother 27:139–150.
  26. Ito A, Yamamoto Y, Ishii Y, Okazaki A, Ishiura Y, Kawagishi Y, Takiguchi Y, Kishi K, Taguchi Y, Shinzato T, Okochi Y, Hayashi R, Nakamori Y, Kichikawa Y, Murata K, Takeda H, Higa F, Miyara T, Saito K, Ishikawa T, Ishida T, Tateda K. 2021. Evaluation of a novel urinary antigen test kit for diagnosing Legionella pneumonia. Int J Infect Dis 103:42–47.
  27. Ghiglione B, Rodríguez MM, Brunetti F, Papp-Wallace KM, Yoshizumi A, Ishii Y, Bonomo RA, Gutkind G, Klinke S, Power P. 2021. Structural and biochemical characterization of the novel CTX-M-151 extended-spectrum β-lactamase and its inhibition by Avibactam. Antimicrob Agents Chemother https://doi.org/10.1128/AAC.01757-20.
  28. Shimada S, Nakai R, Aoki K, Shimoeda N, Ohno G, Kudoh S, Imura S, Watanabe K, Miyazaki Y, Ishii Y, Tateda K. 2021. Chasing Waterborne Pathogens in Antarctic Human-Made and Natural Environments, with Special Reference to Legionella spp. Appl Environ Microbiol 87.
  29. Ota Y, Furuhashi K, Hayashi W, Hirai N, Ishikawa J, Nagura O, Yamanaka K, Katahashi K, Aoki K, Nagano N, Maekawa M. 2021. Daptomycin resistant Enterococcus faecalis has a mutation in liaX, which encodes a surface protein that inhibits the LiaFSR systems and cell membrane remodeling. J Infect Chemother 27:90–93.
  30. Uema M, Yonemitsu K, Momose Y, Ishii Y, Tateda K, Inoue T, Asakura H. 2021. Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface. Biocontrol Sci 26:119–125.
  31. Aoki K, Nagasawa T, Ishii Y, Yagi S, Okuma S, Kashiwagi K, Maeda T, Miyazaki T, Yoshizawa S, Tateda K. 2020. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs. J Infect Chemother https://doi.org/10.1016/j.jiac.2020.11.021.
  32. Kasai T, Fukui Y, Aoki K, Ishii Y, Tateda K. 2020. Changes in the ear canal microbiota of dogs with otitis externa. J Appl Microbiol https://doi.org/10.1111/jam.14868.
  33. Shimada S, Nakai R, Aoki K, Kudoh S, Imura S, Shimoeda N, Ohno G, Watanabe K, Miyazaki Y, Ishii Y, Tateda K. 2021. Characterization of the First Cultured Psychrotolerant Representative of Legionella from Antarctica Reveals Its Unique Genome Structure. Microbiol Spectr 9:e0042421.

 

ページトップへ